Skip to main content


Chronic Lymphocytic Leukemia

Featured

Videos
Alexey Danilov, MD, PhD, discusses acalabrutinib as a treatment option for patients with CLL, SLL, and MCL.
Quiz
True or False: Acalabrutinib demonstrated favorable progression free survival and overall survival compared with…
News
A recent real-world study compared HCRU and costs associated with first-line ibrutinib monotherapy vs bendamustine plus…
Videos
Tara Graff, DO, explains how the introduction of acalabrutinib has impacted the treatment of CLL.
Videos
Jing-Zhou Hou, MD, PhD, discusses dose reductions and discontinuations between patients with CLL receiving ibrutinib in…
Back to Top